Results 71 to 80 of about 182,433 (270)

Activation of Metal Complexes With Ultrasound Waves for Targeted Anticancer Therapy

open access: yesAngewandte Chemie International Edition, EarlyView.
Ultrasound enables non‐invasive activation of metal‐based therapeutics deep within tumors. Acoustic cavitation can drive sonodynamic reactive oxygen species generation or mechanochemical metal–ligand bond dissociation, enabling controlled release of bioactive payloads.
Félix Grosjean   +3 more
wiley   +1 more source

The baseline characteristics and treatment outcome between the patients treated with Pegylated interferon-Alfa-2a and Pegylated interferon-Alfa-2b.

open access: yes, 2014
The baseline characteristics and treatment outcome between the patients treated with Pegylated interferon-Alfa-2a and Pegylated interferon-Alfa-2b.
Tsung-Hsing Hung (579080)   +8 more
core   +1 more source

Retrospective Evaluation of the Treatment Results of Patients with Chronic Hepatitis B and C Infections

open access: yesBoğaziçi Tıp Dergisi, 2020
INTRODUCTION[|]Hepatitis B and hepatitis C infections are the major causes of death due to chronic liver disease. Treatment is very important in reducing long-term cirrhosis and hepatocellular carcinoma. In this study, we aimed to determine the real-life
Servet Öztürk, Nesrin Turker
doaj   +1 more source

Navigating adverse immunostimulation: A practical guide for clinical researchers

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Problem Setting As drug development moves towards more complex products, early clinical development programmes are increasingly hampered by unwanted and/or unexpected activation of the immune system (adverse immune stimulation, AIS). Solution At the Centre for Human Drug Research, we have introduced standardized procedures to make AIS manageable, while
Juliette A. van den Noort   +3 more
wiley   +1 more source

Recurrence of hepatitis C virus after treatment with pegylated interferon and direct acting antivirals in Punjab Pakistan

open access: yesBrazilian Journal of Biology, 2021
Although increased response rates concomitant in hepatitis C virus but relapse after treatment is threatened. Therefore, it is terrible requirement to evaluate the response of Pegylated interferon and direct acting antivirals in Punjab Pakistan.
M. N. Raza   +7 more
doaj   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

open access: yesBMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu   +5 more
wiley   +1 more source

48 Weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achievingHBeAg seroconversion in chronic hepatitis B infection

open access: yes, 2006
Background/Aim Although 48-week therapy with pegylated-interferons has been shown to be effective for the treatment of chronichepatitis B virus (HBV) infection, the efficacy of a shorter durationof therapy with pegylated interferons is unknown.Method We ...
Lo, CM   +11 more
core   +1 more source

PK/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights [PDF]

open access: yes, 2010
Salmon calcitonin (sCT) was conjugated via cysteine-1 to novel comb-shaped end-functionalised (poly(PEG) methyl ether methacrylate) (sCT-P) polymers, to yield conjugates of total molecular weights (MW) inclusive of sCT: 6.5, 9.5, 23 and 40 kDa.
Jesús M. Frías   +15 more
core   +1 more source

Treatment of Autoimmune Haemolytic Anaemia with Hepatitis C Virus-A Real Challenge

open access: yesSri Lankan Journal of Infectious Diseases, 2016
Hepatitis C virus (HCV) infection is a potentially curable disease. The first line of treatment is pegylated interferon and ribavirin, both of which cause haemolysis. HCV itself causes autoimmune haemolytic anaemia (AIHA).
A Basu   +4 more
doaj   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

open access: yesBMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy